Flomax and Skin hypertrophy - a phase IV clinical study of FDA data

Summary:

Skin hypertrophy is reported as a side effect among people who take Flomax (tamsulosin hydrochloride), especially for people who are male, 60+ old, also take Magnevist, and have Nuclear magnetic resonance imaging brain.

The phase IV clinical study analyzes which people have Skin hypertrophy when taking Flomax. It is created by eHealthMe based on reports of 50,469 people who have side effects when taking Flomax from the FDA, and is updated regularly.

What is Flomax?

Flomax has active ingredients of tamsulosin hydrochloride. It is often used in enlarged prostate. eHealthMe is studying from 52,865 Flomax users. Check the latest studies of Flomax.

What is Skin hypertrophy?

Skin hypertrophy (skin cells enlarges) is found to be associated with 595 drugs and 544 conditions by eHealthMe. Check the latest studies of Skin hypertrophy.

On Jul, 06, 2026

50,469 people reported to have side effects when taking Flomax.
Among them, 46 people (0.09%) have Skin hypertrophy.

Among these 46 people:

What is the gender of people who have Skin hypertrophy when taking Flomax? *

female: 6.67 %
male: 93.33 %

What is the age of people who have Skin hypertrophy when taking Flomax? *

What are other drugs people take besides Flomax? *

What are other side effects people have besides Skin hypertrophy? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 31 people, 67.39%
Skin Tightness: 28 people, 60.87%
Pain: 28 people, 60.87%
Joint Range Of Motion Decreased (disease of joint movement): 27 people, 58.70%
Rashes (redness): 26 people, 56.52%
Itching: 26 people, 56.52%
Oedema Peripheral (superficial swelling): 25 people, 54.35%
Dry Skin: 25 people, 54.35%
Weakness: 23 people, 50.00%
Skin Induration (an abnormally hard spot or area on the skin): 21 people, 45.65%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Brain: 19 people, 41.30%
Anaemia (lack of blood): 10 people, 21.74%
Depression: 10 people, 21.74%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 9 people, 19.57%
Polymyalgia Rheumatica (pain in many muscles): 9 people, 19.57%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 4 people, 8.70%
Renal Cell Carcinoma (a kidney cancer): 3 people, 6.52%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 6.52%
Dementia (madness): 3 people, 6.52%
Upper Respiratory Tract Infection: 2 people, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Flomax and have Skin hypertrophy?

- Check whether Skin hypertrophy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flomax:

Flomax (52,865 reports)

Browse all side effects of Flomax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin hypertrophy:

Skin hypertrophy (595 drugs)

Browse all the conditions that are associated with Skin hypertrophy:

Skin hypertrophy (544 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tamsulosin hydrochloride (the active ingredients of Flomax) and Flomax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.